Agencies warn ABQ company over claims

Nootropic says it will update website to comply with warning

An Albuquerque company has been targeted by two federal agencies, which question its claims that such products as “Lion’s Mane” and “Turkey Tail Mushroom Powder” can cure or prevent certain diseases.

Pure Nootropics LLC received a warning letter this month, along with two other companies in Florida and South Carolina, from the Food and Drug Administration and the Federal Trade Commission.

The letter says some of the claims on Pure Nootropic’s website might violate regulations because the products are “not generally recognized as safe and effective” for use against such conditions as diabetes, Alzheimer’s and Parkinson’s disease.

Turkey tail and lion’s mane are types of mushrooms.

Pure Nootropic, in a statement, said the letter is based “primarily on implied claims due to the mention of a disease on our website.” However, none of the company’s products has such claims on its packaging or labels, according to a written statement.

“At the moment, we are currently in the process of developing a corrective action plan in response to the warning letter and the issues it raises,” the statement said. “We will act swiftly to update our website to be in compliance with all applicable rules and regulations and to make certain that it is clear that our products are not intended to diagnose, treat, or cure any disease.”

The agencies, in their warning letter, targeted Pure Nootropic’s website claims about seven of its products. Among some of them:

Alpha GPC 50% Capsules and Powder are “Helpful in reducing symptoms of cognitive decline... (prescribed in Europe to Alzheimer’s patients)"

Turkey Tail Mushroom Powder helps “to fight infections, illness and diseases.”

Piracetam Capsules Subscription — “Major diseases, such as dementia, schizophrenia, Alzheimer’s and Parkinson’s, have all been treated using piracetam. Even dyslexia can be improved with piracetam usage.”